Eur. Urol. 2013 Mar 26
Personalizing the management of men with intermediate-risk prostate cancer.
Related Questions
New comment by Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center ( May 5, 2025)
Dr. @Williams -
Happy to share my thoughts and how I approach it. There are currently multiple gaps in evidence for GG2 cancer. Your case is a low volume FIR GG2 cancer,...